FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

Key Highlights

• FDA rejected Moderna's flu vaccine application due to lack of adequate trials.
• Experts claim the decision reflects an anti-vaccine agenda.
• The FDA labeled Moderna's clinical trial a 'brazen failure'.
• The rejection could negatively impact future vaccine research and development.